Weather , , 0°C

Phenylketonuria Pipeline Drugs and Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

 Breaking News
  • No posts were found

Phenylketonuria Pipeline Drugs and Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

July 22
22:35 2021
Phenylketonuria Pipeline Drugs and Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

DelveInsight Business Research LLP
DelveInsight’s, “Phenylketonuria – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Phenylketonuria pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

DelveInsight’s “Phenylketonuria Pipeline Insight” report provides comprehensive insights about key companies and pipeline drugs in the Phenylketonuria pipeline landscapes. It comprises Phenylketonuria pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Phenylketonuria therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Phenylketonuria pipeline products.     

Some of the key takeaways of the Phenylketonuria Pipeline Report

  • Companies across the globe are diligently working toward the development of novel treatment therapies with a considerable amount of success over the years. Key players, such as Synlogic, Censa Pharmaceuticals, Homology Medicines, Biomarin Pharmaceuticals, etc., are developing therapies to treat Phenylketonuria.

  • Emerging therapies such as SYNB1618, CNSA-001, HMI-102, BMN 307, are expected to have a significant impact on the Phenylketonuria market in the coming years.

  • Rising mergers and acquisitions and collaboration activities among the major market participants are also estimated to drive the phenylketonuria treatment market. 

Get an overview of pipeline landscape @ Phenylketonuria Clinical Trials Analysis

Phenylketonuria (PKU) is an inborn error of metabolism that is detectable during the first days of life via routine newborn screening. PKU is characterized by the absence or deficiency of an enzyme called phenylalanine hydroxylase (PAH), responsible for processing the amino acid phenylalanine.

Phenylketonuria Emerging Drugs

  1. SYNB1618 by Synlogic

  2. CNSA-001 by Censa Pharmaceuticals

  3. HMI-102 by Homology Medicines

  4. BMN 307 by Biomarin Pharmaceuticals

  5. And others.

Scope of Phenylketonuria Pipeline Drug Insight    

  • Coverage: Global 

  • Major Players: Synlogic, Censa Pharmaceuticals, Homology Medicines, Biomarin Pharmaceuticals, and others.

  • Pipeline Therapies: SYNB1618, CNSA-001, HMI-102, BMN 307, and others.

Table of Contents

1

Phenylketonuria Report Introduction

2

Phenylketonuria Executive Summary

3

Phenylketonuria Overview

4

Phenylketonuria- Analytical Perspective In-depth Commercial Assessment

5

Phenylketonuria Pipeline Therapeutics

6

Phenylketonuria Late Stage Products (Phase II/III)

7

Phenylketonuria Mid Stage Products (Phase II)

8

Phenylketonuria Early Stage Products (Phase I)

9

Phenylketonuria Preclinical Stage Products

10

Phenylketonuria Therapeutics Assessment

11

Phenylketonuria Inactive Products

12

Company-University Collaborations (Licensing/Partnering) Analysis

13

Phenylketonuria Key Companies

14

Phenylketonuria Key Products

15

Phenylketonuria Unmet Needs

16 

Phenylketonuria Market Drivers and Barriers

17

Phenylketonuria Future Perspectives and Conclusion

18

Phenylketonuria Analyst Views

19

Appendix

20

About DelveInsight

Related Reports:

Phenylketonuria Market

DelveInsight’s Phenylketonuria – Market Insights, Epidemiology, and Market Forecast-2030 report delivers an in-depth understanding of the Phenylketonuria, historical and forecasted epidemiology as well as the Phenylketonuria market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Phenylketonuria Epidemiology

DelveInsight’s ‘ Phenylketonuria- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted  Phenylketonuria epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Related Articles

Calendar

December 2021
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Categories